Cargando…

Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism

Non-alcoholic fatty liver disease (NAFLD) is a liver disease syndrome. The prevalence of NAFLD has continued to increase globally, and NAFLD has become a worldwide public health problem. Glucosamine (GLC) is an amino monosaccharide derivative of glucose. GLC has been proven to not only be effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng, Zhang, Zhengyan, Bai, Yan, Che, Qishi, Cao, Hua, Guo, Jiao, Su, Zhengquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574579/ https://www.ncbi.nlm.nih.gov/pubmed/37836761 http://dx.doi.org/10.3390/molecules28196918

Ejemplares similares

GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes
por: Qiu, Shuting, et al.
Publicado: (2022)

Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?
por: Chen, Jiajia, et al.
Publicado: (2020)

Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
por: Feng, Jiayao, et al.
Publicado: (2022)

Galacto-Oligosaccharide Alleviates Alcohol-Induced Liver Injury by Inhibiting Oxidative Stress and Inflammation
por: Zhou, Shipeng, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
por: Longato, Lisa
Publicado: (2013)

Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats
por: Huang, Lanlan, et al.
Publicado: (2015)

Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
por: Xiang, Junwei, et al.
Publicado: (2021)

The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota
por: You, Huimin, et al.
Publicado: (2022)

Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease
por: Maldonado, Elaina M., et al.
Publicado: (2018)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol
por: Eng, James M., et al.
Publicado: (2021)

Characteristics of intestinal microbiota in C57BL/6 mice with non-alcoholic fatty liver induced by high-fat diet
por: Yan, Guangwen, et al.
Publicado: (2022)

Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury
por: Guo, Xinghua, et al.
Publicado: (2023)

Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice
por: Ohashi, Tomohiko, et al.
Publicado: (2019)

Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
por: Pei, Erli, et al.
Publicado: (2018)

Nonylphenol aggravates non-alcoholic fatty liver disease in high sucrose-high fat diet-treated rats
por: Yu, Jie, et al.
Publicado: (2018)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Effects of exercise on high-fat diet–induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice
por: Huang, Wen-Ching, et al.
Publicado: (2022)

Oudemansiella raphanipies Polysaccharides Improve Lipid Metabolism Disorders in Murine High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
por: Jiang, Haitao, et al.
Publicado: (2022)

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function
por: Yu, Shenglan, et al.
Publicado: (2022)

High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis
por: Xin, Xin, et al.
Publicado: (2020)

Study on the effect of different types of sugar on lipid deposition in goose fatty liver
por: Wei, Rongxue, et al.
Publicado: (2022)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Liver Oxidative Status, Serum Lipids Levels after Bariatric Surgery and High-Fat, High-Sugar Diet in Animal Model of Induced Obesity
por: Kazura, Wojciech, et al.
Publicado: (2023)

Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats
por: Ma, Zhihong, et al.
Publicado: (2017)

Herbal formulation MIT ameliorates high-fat diet-induced non-alcoholic fatty liver disease
por: Ahn, Sang-hyun, et al.
Publicado: (2020)

Can Zinc Supplementation Attenuate High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease?
por: Bolatimi, Oluwanifemi Esther, et al.
Publicado: (2023)

Monobutyrin Reduces Liver Cholesterol and Improves Intestinal Barrier Function in Rats Fed High-Fat Diets
por: Nguyen, Thao Duy, et al.
Publicado: (2019)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Glucosamine Ameliorates Symptoms of High-Fat Diet-Fed Mice by Reversing Imbalanced Gut Microbiota
por: Yuan, Xubing, et al.
Publicado: (2021)

Assessment of high-fat-diet-induced fatty liver in medaka
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats
por: Zhao, Hui, et al.
Publicado: (2022)

The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
por: Moore, J. Bernadette, et al.
Publicado: (2014)

Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Liu, Lu, et al.
Publicado: (2023)

Non-shivering Thermogenesis Signalling Regulation and Potential Therapeutic Applications of Brown Adipose Tissue
por: Zhang, Zhengyan, et al.
Publicado: (2021)

Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4h3euvakd0su5ccg0s5rv0fbb